MorphoSys Research Site

Ibaraki 311-3193

0 studies enrolling now · 1 studies all time

What they study most

Diffuse Large B-cell Lymphoma

Studies at this site

• Tafasitamab + Lenalidomide + R-CHOP Versus R-CHOP in Newly Diagnosed High-intermediate and High Risk DLBCL Patients — Running, not enrolling